Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Dietmar Berger currently holds 46,928 shares of Atara Biotherapeutics, Inc. (ATRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dietmar Berger has been a net neutral trader of ATRA stock. They have purchased $0 and sold $0 worth of shares.
Dietmar Berger's most recent insider trade was on Jun 10, 2026, when they sold 533 shares at $0.00 per share.
Dietmar Berger serves as Executive at Atara Biotherapeutics, Inc. (ATRA). They have executed 10 insider transactions totaling $0 over their tenure at the company.
Dietmar Berger holds the position of Executive at Atara Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Dietmar Berger has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Dietmar Berger was on Jan 2, 2026, when they sold $844.4K worth of GILD shares. This transaction involved 6,944 shares at $121.60 per share.
Dietmar Berger currently owns 46,928 shares of Atara Biotherapeutics, Inc. (ATRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Dietmar Berger's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Dietmar Berger has 10 Form 4 filings on record as an insider at Atara Biotherapeutics, Inc..
Set alerts for Dietmar Berger and 40,000+ other insiders.